D. E. Shaw & Co., Inc. - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 113 filers reported holding ASSERTIO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$2,092,000
-62.9%
3,219,102
-28.6%
0.00%
-50.0%
Q4 2019$5,633,000
+21.3%
4,506,585
+24.2%
0.01%0.0%
Q3 2019$4,644,000
+15.3%
3,628,098
+210.8%
0.01%
+20.0%
Q2 2019$4,027,000
-17.5%
1,167,154
+21.2%
0.01%
-16.7%
Q1 2019$4,883,000
+90.1%
963,018
+35.4%
0.01%
+50.0%
Q4 2018$2,568,000
-44.6%
711,287
-9.8%
0.00%
-33.3%
Q3 2018$4,636,000788,4280.01%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 3,278,000$11,834,0000.90%
Senvest Management, LLC 2,124,393$7,669,0000.66%
DELTEC ASSET MANAGEMENT LLC 351,176$1,268,0000.35%
PERKINS CAPITAL MANAGEMENT INC 99,600$360,0000.28%
Matarin Capital Management, LLC 838,619$3,027,415,0000.24%
GLOBEFLEX CAPITAL L P 196,357$709,0000.17%
Opaleye Management Inc. 120,000$433,0000.16%
TSP Capital Management Group, LLC 49,175$178,0000.10%
Spark Investment Management LLC 373,609$1,348,0000.09%
Connor, Clark & Lunn Investment Management Ltd. 3,191,964$11,523,0000.08%
View complete list of ASSERTIO THERAPEUTICS INC shareholders